Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

Despite the withdrawal of the HeartWare Ventricular Assist Device (HVAD), hundreds of patients are still supported with this continuous-flow pump, and the long-term management of these patients is still under debate. This study aims to analyse 5 years survival and freedom from major adverse events i...

Full description

Bibliographic Details

Published in:	Transplant International
Main Authors:	Alessandra Francica, Antonio Loforte, Matteo Attisani, Massimo Maiani, Attilio Iacovoni, Teodora Nisi, Marina Comisso, Amedeo Terzi, Michele De Bonis, Igor Vendramin, Massimo Boffini, Francesco Musumeci, Giovanni Battista Luciani, Mauro Rinaldi, Davide Pacini, Francesco Onorati
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Subjects:	continuous-flow LVAD HeartMate3 HeartWare full-magnetic levitation pump hybrid levitation system pump
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11675/full